Somalogic Inc (NASDAQ:SLGC) — Market Cap & Net Worth
Market Cap & Net Worth: Somalogic Inc (SLGC)
Somalogic Inc (NASDAQ:SLGC) has a market capitalization of $396.23 Million ($396.23 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13635 globally and #3234 in its home market, demonstrating a -0.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Somalogic Inc's stock price $19.32 by its total outstanding shares 188679008 (188.68 Million). Review SLGC total liabilities to assess the company's total debt and financial obligations.
Somalogic Inc Market Cap History: 2026 to 2026
Somalogic Inc's market capitalization history from 2026 to 2026. Data shows growth from $3.65 Billion to $3.65 Billion (0.00% CAGR).
Somalogic Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Somalogic Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLGC by Market Capitalization
Companies near Somalogic Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Somalogic Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1017 globally with a market cap of $26.54 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1955 globally with a market cap of $12.13 Billion USD ( AU$17.14 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2173 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2489 globally with a market cap of $8.78 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1017 | Veeva Systems Inc Class A | NYSE:VEEV | $26.54 Billion | $163.38 |
| #1955 | Pro Medicus Ltd | AU:PME | $12.13 Billion | AU$164.11 |
| #2173 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $64.14 |
| #2489 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.78 Billion | $50.56 |
Somalogic Inc Historical Marketcap From 2026 to 2026
Between 2026 and today, Somalogic Inc's market cap moved from $3.65 Billion to $ 3.65 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.65 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Somalogic Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $396.23 Million USD |
| MoneyControl | $396.23 Million USD |
| MarketWatch | $396.23 Million USD |
| marketcap.company | $396.23 Million USD |
| Reuters | $396.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Somalogic Inc
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in … Read more